Direct visualization of HIV-enhancing endogenous amyloid fibrils in human semen

Nature Communications

Volumn 5, Issue , 2014, Pages

  Usmani, Shariq M ^a   Zirafi, Onofrio ^a   Müller, Janis A ^a   Sandi Monroy, Nathallie L ^a,b   Yadav, Jay K ^c   Meier, Christoph ^c   Weil, Tanja ^c   Roan, Nadia R ^d,e   Greene, Warner C ^e,f   Walther, Paul ^c   Nilsson, K Peter R ^g   Hammarström, Per ^g   Wetzel, Ronald ^h   Pilcher, Christopher D ^d   Gagsteiger, Friedrich ^b   Fändrich, Marcus ^c   Kirchhoff, Frank ^a   Münch, Jan ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b Kinderwunsch Zentrum Ulm   (Germany)

^c UNIVERSITY OF ULM   (Germany)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e GLADSTONE INSTITUTE OF VIROLOGY AND IMMUNOLOGY   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g LINKÖPING UNIVERSITY   (Sweden)

^h UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; AMYLOID;

AGGREGATE; BODY FLUID; DISEASE TRANSMISSION; ELECTRON MICROSCOPY; FUNCTIONAL ROLE; HOMINID; HUMAN IMMUNODEFICIENCY VIRUS; IMAGING METHOD; INFECTIVITY; MEDICINE; PATHOLOGY; PROTEIN;

ADULT; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MALE; PROTEIN ANALYSIS; SPERM; VIRUS INFECTIVITY;

AMYLOID; HIV INFECTIONS; HIV-1; HUMANS; MALE; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, TRANSMISSION; PROTEIN TYROSINE PHOSPHATASES; SEMEN; SEMINAL VESICLE SECRETORY PROTEINS;

EID: 84897547506     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms4508     Document Type: Article

References (37)

1. Lederman, M. M., Offord, R. E. & Hartley, O. Microbicides and other topical strategies to prevent vaginal transmission of HIV. Nat. Rev. Immunol. 6, 371-382 (2006).
2. Shaw, G. M. & Hunter, E. HIV transmission. Cold Spring. Harb. Perspect. Med. 2 pii: a006965 (2012).
3. Gupta, K. & Klasse, P. J. How do viral and host factors modulate the sexual transmission of HIV? Can transmission be blocked? PLoS Med. 3, e79 (2006).
4. Haase, A. T. Early events in sexual transmission of HIV and SIV and opportunities for interventions. Annu. Rev. Med. 62, 127-139 (2011).
5. Allen, R. D. & Roberts, T. K. The relationship between the immunosuppressive and cytotoxic effects of human seminal plasma. Am. J. Reprod. Immunol. Microbiol. 11, 59-64 (1987).
6. Allen, R. D. & Roberts, T. K. Role of spermine in the cytotoxic effects of seminal plasma. Am. J. Reprod. Immunol. Microbiol. 13, 4-8 (1987). (Pubitemid 17020553)
7. Fiore, J. R. et al. The use of serum-free medium delays, but does not prevent, the cytotoxic effects of seminal plasma in lymphocyte cultures: implications for studies on HIV infection. New Microbiol. 20, 339-344 (1997). (Pubitemid 127527565)
8. Kiessling, A. A. Isolation of human immunodeficiency virus type 1 from semen and vaginal fluids. Methods Mol. Biol. 304, 71-86 (2005).
9. Okamoto, M. et al. Seminal plasma induces programmed cell death in cultured peripheral blood mononuclear cells. AIDS Res. Hum. Retroviruses 18, 797-803 (2002).
10. Bouhlal, H. et al. Opsonization of HIV-1 by semen complement enhances infection of human epithelial cells. J. Immunol. 169, 3301-3306 (2002). (Pubitemid 35013178)
11. Münch, J. et al. Semen-derived amyloid fibrils drastically enhance HIV infection. Cell 131, 1059-1071 (2007). (Pubitemid 350235017)
12. Hauber, I., Hohenberg, H., Holstermann, B., Hunstein, W. & Hauber, J. The main green tea polyphenol epigallocatechin-3-gallate counteracts semenmediated enhancement of HIV infection. Proc. Natl Acad. Sci. USA 106, 9033-9038 (2009).
13. Kim, K. A. et al. Semen-mediated enhancement of HIV infection is donordependent and correlates with the levels of SEVI. Retrovirology 7, 55 (2010).
14. Roan, N. R. et al. The cationic properties of SEVI underlie its ability to enhance human immunodeficiency virus infection. J. Virol. 83, 73-80 (2009).
15. Roan, N. R., Sowinski, S., Münch, J., Kirchhoff, F. & Greene, W. C. Aminoquinoline surfen inhibits the action of SEVI (semen-derived enhancer of viral infection). J. Biol. Chem. 285, 1861-1869 (2010).
16. Olsen, J. S. et al. Amyloid-binding small molecules efficiently block SEVI (semen-derived enhancer of virus infection)- and semen-mediated enhancement of HIV-1 infection. J. Biol. Chem. 285, 35488-35496 (2010).
17. Roan, N. R. et al. Peptides released by physiological cleavage of semen coagulum proteins form amyloids that enhance HIV infection. Cell Host Microbe. 10, 541-550 (2011).
18. Doncel, G. F., Joseph, T. & Thurman, A. R. Role of semen in HIV-1 transmission: inhibitor or facilitator? Am. J. Reprod. Immunol. 65, 292-301 (2011).
19. Castellano, L. M. & Shorter, J. The surprising role of amyloid fibrils in HIV infection. Biology 1, 58-80 (2012).
20. Arnold, F. et al. Naturally occurring fragments from two distinct regions of the prostatic acid phosphatase form amyloidogenic enhancers of HIV infection. J. Virol. 86, 1244-1249 (2012).
21. Nanga, R. P., Brender, J. R., Vivekanandan, S., Popovych, N. & Ramamoorthy, A. NMR structure in a membrane environment reveals putative amyloidogenic regions of the SEVI precursor peptide PAP(248-286). J. Am. Chem. Soc. 131, 17972-17979 (2009).
22. Wojtowicz, W. M. et al. Stimulation of enveloped virus infection by betaamyloid fibrils. J. Biol. Chem. 277, 35019-35024 (2002).
23. Yolamanova, M. et al. Peptide nanofibrils boost retroviral gene transfer and provide a rapid means for concentrating viruses. Nat. Nanotechnol. 8, 130-136 (2013).
24. Sheftic, S. R., Snell, J. M., Jha, S. & Alexandrescu, A. T. Inhibition of semenderived enhancer of virus infection (SEVI) fibrillogenesis by zinc and copper. Eur. Biophys. J. 41, 695-704 (2012).
25. Popovych, N. et al. Site specific interaction of the polyphenol EGCG with the SEVI amyloid precursor peptide PAP(248-286). J. Phys. Chem. B 116, 3650-3658 (2012).
26. Sievers, S. A. et al. Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation. Nature 475, 96-100 (2011).
27. Capule, C. C., Brown, C., Olsen, J. S., Dewhurst, S. & Yang, J. Oligovalent amyloid-binding agents reduce SEVI-mediated enhancement of HIV-1 infection. J. Am. Chem. Soc. 134, 905-908 (2012).
28. Nilsson, M. R. Techniques to study amyloid fibril formation in vitro. Methods 34, 151-160 (2004). (Pubitemid 38993215)
29. Picken, M. M. Amyloidosis-where are we now and where are we heading? Arch. Pathol. Lab. Med. 134, 545-551 (2010).
30. Easterhoff, D. et al. Fluorescence detection of cationic amyloid fibrils in human semen. Bioorg. Med. Chem. Lett. 23, 5199-5202 (2013).
31. Pawley, J. B. (editor) Handbook of Biological Confocal Microscopy 3rd edn, 1-19 (Springer, Berlin, 2006).
32. Shen, D. et al. Novel cell- and tissue-based assays for detecting misfolded and aggregated protein accumulation within aggresomes and inclusion bodies. Cell Biochem. Biophys. 60, 173-185 (2011).
33. Nilsson, K. P., Lindgren, M. & Hammarström, P. A pentameric luminescentconjugated oligothiophene for optical imaging of in vitro-formed amyloid fibrils and protein aggregates in tissue sections. Methods Mol. Biol. 849, 425-434 (2012).
34. O'Nuallain, B. & Wetzel, R. Conformational Abs recognizing a generic amyloid fibril epitope. Proc. Natl Acad. Sci. USA 99, 1485-1490 (2002). (Pubitemid 34136519)
35. Tang, Q., Roan, N. R. & Yamamura, Y. Seminal plasma and semen amyloids enhance cytomegalovirus infection in cell culture. J. Virol. 87, 12583-12591 (2013).
36. Fowler, D. M. et al. Functional amyloid formation within mammalian tissue. PLoS Biol. 4, e6 (2006).
37. Easterhoff, D. et al. Semen-derived enhancer of viral infection (SEVI) binds bacteria, enhances bacterial phagocytosis by macrophages, and can protect against vaginal infection by a sexually transmitted bacterial pathogen. Antimicrob. Agents Chemother. 57, 2443-2450 (2013).